Leamington, Ontario – November 2, 2016 – Aphria Inc. (“Aphria” or the “Company”) (TSX-V: APH or USOTCQB: APHQF) announced that the Board of Directors of the Company granted 1,000,000 options to purchase common stock to various directors, officers, employees and consultants, at an exercise price of $3.90, for a term of three years, pursuant to the Company’s incentive stock option plan. We have A Good Thing Growing. About Aphria Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licenced producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters. For more information, visit www.Aphria.com.